DK164485C - Polymerholdige medikamenter, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende mindst et saadant medikament - Google Patents
Polymerholdige medikamenter, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende mindst et saadant medikamentInfo
- Publication number
- DK164485C DK164485C DK003386A DK3386A DK164485C DK 164485 C DK164485 C DK 164485C DK 003386 A DK003386 A DK 003386A DK 3386 A DK3386 A DK 3386A DK 164485 C DK164485 C DK 164485C
- Authority
- DK
- Denmark
- Prior art keywords
- peptide
- mol
- units derived
- bound
- methacryloylated
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 7
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000000975 bioactive effect Effects 0.000 abstract 2
- PQFMNVGMJJMLAE-QMMMGPOBSA-N L-tyrosinamide Chemical compound NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PQFMNVGMJJMLAE-QMMMGPOBSA-N 0.000 abstract 1
- 238000004166 bioassay Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- OKPYIWASQZGASP-UHFFFAOYSA-N n-(2-hydroxypropyl)-2-methylprop-2-enamide Chemical compound CC(O)CNC(=O)C(C)=C OKPYIWASQZGASP-UHFFFAOYSA-N 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 125000006850 spacer group Chemical group 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
- Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
- Y10S530/815—Carrier is a synthetic polymer
- Y10S530/816—Attached to the carrier via a bridging agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858500209A GB8500209D0 (en) | 1985-01-04 | 1985-01-04 | Synthetic polymeric drugs |
GB8500209 | 1985-01-04 |
Publications (4)
Publication Number | Publication Date |
---|---|
DK3386D0 DK3386D0 (da) | 1986-01-03 |
DK3386A DK3386A (da) | 1986-07-05 |
DK164485B DK164485B (da) | 1992-07-06 |
DK164485C true DK164485C (da) | 1992-11-23 |
Family
ID=10572420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK003386A DK164485C (da) | 1985-01-04 | 1986-01-03 | Polymerholdige medikamenter, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende mindst et saadant medikament |
Country Status (9)
Country | Link |
---|---|
US (1) | US5037883A (da) |
EP (1) | EP0187547B1 (da) |
JP (2) | JPH075474B2 (da) |
AT (1) | ATE60991T1 (da) |
AU (1) | AU589587B2 (da) |
CA (1) | CA1305053C (da) |
DE (1) | DE3581921D1 (da) |
DK (1) | DK164485C (da) |
GB (1) | GB8500209D0 (da) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4738434A (en) | 1986-04-07 | 1988-04-19 | Marjoram Robert H | Vibration and/or shock attenuating fluid mount or the like |
JP2896580B2 (ja) * | 1989-08-25 | 1999-05-31 | チッソ株式会社 | アミロース―リゾチームハイブリッドと活性化糖およびその製造法 |
EP0452179B1 (en) * | 1990-03-28 | 1996-06-12 | Nippon Oil And Fats Company, Limited | Polymer-combined drug for gastric treatment and a method for producing the drug |
CA2046830C (en) | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
CZ2190U1 (cs) * | 1991-02-01 | 1994-07-14 | Alexandr Rndr. Csc. Jegorov | Směrované polymerní konjugáty cyklosporinu |
US5332575A (en) * | 1991-10-03 | 1994-07-26 | Parfums Christian Dior | Method of targeting melanocytes with a compound containing a fucose residue |
US5258453A (en) * | 1992-01-21 | 1993-11-02 | University Of Utah | Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light |
GB9213077D0 (en) * | 1992-06-19 | 1992-08-05 | Erba Carlo Spa | Polymerbound taxol derivatives |
GB2270920B (en) * | 1992-09-25 | 1997-04-02 | Univ Keele | Alginate-bioactive agent conjugates |
US7056935B2 (en) | 1995-06-07 | 2006-06-06 | Gpi Nil Holdings, Inc. | Rotamase enzyme activity inhibitors |
GB9600471D0 (en) * | 1996-01-10 | 1996-03-13 | Univ London Pharmacy | Drug delivery system |
GB9606975D0 (en) * | 1996-04-02 | 1996-06-05 | Univ Birmingham | Anti-tumor agent |
DE69734709D1 (de) * | 1996-04-15 | 2005-12-29 | Asahi Chemical Ind | Arzneimittelkomplexe enthaltend taxan-verbindungen oder steroiden |
AU7124598A (en) * | 1997-04-18 | 1998-11-13 | Access Pharmaceuticals, Inc. | Polymer-platinum compounds |
US5965118A (en) * | 1997-04-18 | 1999-10-12 | Access Pharmaceuticals, Inc. | Polymer-platinum compounds |
US6251866B1 (en) | 1997-08-05 | 2001-06-26 | Watson Laboratories, Inc. | Conjugates targeted to the interleukin-2 receptor |
US6180084B1 (en) * | 1998-08-25 | 2001-01-30 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
US6066673A (en) * | 1998-03-12 | 2000-05-23 | The Procter & Gamble Company | Enzyme inhibitors |
US7018654B2 (en) | 1999-03-05 | 2006-03-28 | New River Pharmaceuticals Inc. | Pharmaceutical composition containing an active agent in an amino acid copolymer structure |
US7060708B2 (en) | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
WO2001036002A1 (en) * | 1999-11-17 | 2001-05-25 | School Of Pharmacy, University Of London | Conjugates of hpma copolymer and ellipticin |
DK1257269T3 (da) | 2000-02-24 | 2005-03-14 | Kopran Res Lab Ltd | Syrestabile benzimidazolderivater til oral indgivelse mod ulcus |
ES2294026T3 (es) | 2000-09-06 | 2008-04-01 | Ap Pharma, Inc. | Polimeros degradables de poliacetal. |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
WO2002090390A1 (en) * | 2001-05-04 | 2002-11-14 | University Of Utah Research Foundation | Hyaluronic acid containing bioconjugates : targeted delivery of anti-cancer drugs to cancer cells |
US20060014697A1 (en) | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
US7375082B2 (en) | 2002-02-22 | 2008-05-20 | Shire Llc | Abuse-resistant hydrocodone compounds |
US7338939B2 (en) | 2003-09-30 | 2008-03-04 | New River Pharmaceuticals Inc. | Abuse-resistant hydrocodone compounds |
US20030124742A1 (en) * | 2001-08-22 | 2003-07-03 | Prakash Ramesh K. | Conjugates targeted to target receptors |
WO2003072046A2 (en) | 2002-02-22 | 2003-09-04 | New River Pharmaceuticals Inc. | Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances |
US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
CZ293787B6 (cs) * | 2001-12-20 | 2004-07-14 | Zentiva, A.S. | pH senzitivní polymerní konjugáty antracyklinového kancerostatika pro cílenou terapii |
US7105486B2 (en) | 2002-02-22 | 2006-09-12 | New River Pharmaceuticals Inc. | Abuse-resistant amphetamine compounds |
US7659253B2 (en) | 2002-02-22 | 2010-02-09 | Shire Llc | Abuse-resistant amphetamine prodrugs |
US7700561B2 (en) | 2002-02-22 | 2010-04-20 | Shire Llc | Abuse-resistant amphetamine prodrugs |
JP4514455B2 (ja) * | 2002-04-11 | 2010-07-28 | チルドレンズ メディカル センター コーポレーション | Tnp−470ポリマー複合体及びその使用 |
CA2480809A1 (en) * | 2002-04-11 | 2003-10-23 | Children's Medical Center Corporation | Methods for inhibiting vascular hyperpermeability |
CA2483696A1 (en) * | 2002-05-06 | 2003-11-20 | University Of Utah Research Foundation | Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
US20040116348A1 (en) * | 2002-09-23 | 2004-06-17 | Ying Chau | Polymer-linker-drug conjugates for targeted drug delivery |
US8133881B2 (en) | 2003-01-13 | 2012-03-13 | Shire Llc | Carbohydrate conjugates to prevent abuse of controlled substances |
PL1604687T3 (pl) * | 2003-03-20 | 2011-04-29 | Nippon Kayaku Kk | Preparat micelarny zawierający słabo rozpuszczalny w wodzie lek przeciwnowotworowy oraz nowy kopolimer blokowy |
EP1613274B1 (en) | 2003-04-15 | 2010-03-03 | GlaxoSmithKline LLC | Human il-18 substitution mutants and their conjugates |
NZ544162A (en) | 2003-05-29 | 2008-09-26 | Shire Llc | Abuse resistant amphetamine compounds |
MXPA06003619A (es) | 2003-09-30 | 2008-01-14 | New River Pharmaceuticals Inc | Composiciones farmaceuticas para prevencion de sobredosis o abuso. |
KR101520209B1 (ko) * | 2003-11-06 | 2015-05-13 | 시애틀 지네틱스, 인크. | 리간드에 접합될 수 있는 모노메틸발린 화합물 |
CA2557448C (en) * | 2004-03-31 | 2015-06-23 | University Of Utah Research Foundation | Macromolecular delivery systems for non-invasive imaging, evaluation and treatment of arthritis and other inflammatory diseases |
CA2581125C (en) | 2004-09-22 | 2013-04-23 | Nippon Kayaku Kabushiki Kaisha | Modified poly(ethylene oxide-amino acid) copolymer, micelle preparation, and anticancer agent containing the same |
KR100761411B1 (ko) | 2005-01-14 | 2007-10-04 | 한국과학기술연구원 | 담즙산-키토산 복합체 내부에 소수성 항암제가 봉입된 제형 및 그의 제조방법 |
WO2006084054A2 (en) * | 2005-02-02 | 2006-08-10 | Children's Medical Center Corporation | Method of treating angiogenic diseases |
WO2007111211A1 (ja) | 2006-03-28 | 2007-10-04 | Nippon Kayaku Kabushiki Kaisha | タキサン類の高分子結合体 |
RU2447095C2 (ru) | 2006-05-18 | 2012-04-10 | Ниппон Каяку Кабусики Кайся | Высокомолекулярный конъюгат подофиллотоксинов |
WO2007143209A2 (en) * | 2006-06-02 | 2007-12-13 | University Of Virginia Patent Foundation | Luminescent diketonate polymers |
WO2008041610A1 (fr) * | 2006-10-03 | 2008-04-10 | Nippon Kayaku Kabushiki Kaisha | Mélange d'un dérivé de résorcinol avec un polymère |
US8334364B2 (en) | 2006-11-06 | 2012-12-18 | Nipon Kayaku Kabushiki Kaisha | High-molecular weight derivative of nucleic acid antimetabolite |
JP5548365B2 (ja) | 2006-11-08 | 2014-07-16 | 日本化薬株式会社 | 核酸系代謝拮抗剤の高分子誘導体 |
CN1973902B (zh) * | 2006-12-12 | 2010-11-10 | 东北师范大学 | 以人参多糖为载体的抗肿瘤药物阿霉素复合物及制备方法 |
US8703878B2 (en) | 2007-09-28 | 2014-04-22 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of steroids |
US8920788B2 (en) | 2008-03-18 | 2014-12-30 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of physiologically active substances |
WO2009136572A1 (ja) | 2008-05-08 | 2009-11-12 | 日本化薬株式会社 | 葉酸若しくは葉酸誘導体の高分子結合体 |
US9434610B2 (en) * | 2008-10-07 | 2016-09-06 | Rexahn Pharmaceuticals, Inc. | HPMA—docetaxel conjugates and uses therefore |
WO2010131675A1 (ja) | 2009-05-15 | 2010-11-18 | 日本化薬株式会社 | 水酸基を有する生理活性物質の高分子結合体 |
KR101721865B1 (ko) | 2009-10-13 | 2017-04-03 | 렉산 파마슈티컬스, 인코포레이티드 | 항암제의 전달을 위한 폴리머 시스템 |
CZ302830B6 (cs) * | 2009-12-15 | 2011-11-30 | Ústav makromolekulární chemie AV CR, v.v.i. | Vysokomolekulární polymerní nosice léciv odvozené od dendrimeru a jejich konjugáty s lécivy pro lécbu zejména pevných nádoru |
US9289510B2 (en) | 2010-03-08 | 2016-03-22 | University Of Utah Research Foundation | Polymeric drug delivery conjugates and methods of making and using thereof |
EP3858385A3 (en) | 2010-05-25 | 2021-10-27 | Syndevrx, Inc. | Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
US9895449B2 (en) | 2010-05-25 | 2018-02-20 | Syndevrx, Inc. | Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof |
JP5856069B2 (ja) | 2010-11-17 | 2016-02-09 | 日本化薬株式会社 | 新規なシチジン系代謝拮抗剤の高分子誘導体 |
CA2827029C (en) | 2011-02-11 | 2019-07-02 | The Regents Of The University Of Michigan | Tripeptide compositions and methods |
ES2635117T3 (es) | 2011-09-11 | 2017-10-02 | Nippon Kayaku Kabushiki Kaisha | Método para la fabricación de un copolímero de bloques |
US10251906B2 (en) | 2013-03-12 | 2019-04-09 | University Of Utah Research Foundation | Compositions and methods for inducing apoptosis |
BR112015025892A2 (pt) | 2013-04-10 | 2017-07-25 | Syndevrx Inc | inibidores de metap2 e métodos para tratar obesidade |
CN103965398B (zh) * | 2014-04-11 | 2016-04-13 | 西北师范大学 | D-半乳糖/苯甲醛氮芥/n-(2-羟丙基)甲基丙烯酰胺共聚物及其制备和应用 |
JP2019501898A (ja) | 2015-12-10 | 2019-01-24 | シンデブルックス,インコーポレイティド | フマギロール誘導体およびその多形体 |
WO2017123603A1 (en) | 2016-01-11 | 2017-07-20 | Syndevrx, Inc. | Treatment for tumors driven by metabolic dysfunction |
WO2018118903A1 (en) | 2016-12-19 | 2018-06-28 | The Regents Of The University Of California | Noncrushable pill formulatiions |
EP3555280A4 (en) | 2016-12-19 | 2020-09-09 | The Regents of The University of California | DUAL ENZYME-RESPONDING PEPTIDES |
BR112019021742A2 (pt) | 2017-04-17 | 2020-05-05 | Univ Chicago | composição, sistema, composição farmacêutica, composição alimentícia ou nutracêutica, método e uso da composição |
US10894019B2 (en) | 2017-08-15 | 2021-01-19 | University Of South Carolina | Drug delivery system and method for targeting cancer stem cells |
JP2022512826A (ja) | 2018-10-26 | 2022-02-07 | シンデブルックス,インコーポレイティド | MetAP2阻害剤のバイオマーカーとその応用 |
US11672767B2 (en) | 2019-05-13 | 2023-06-13 | University Of South Carolina | Enzymatically cleavable self-assembled nanoparticles for morphogen delivery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL133221C (da) * | 1965-11-12 | |||
US3957700A (en) * | 1972-05-04 | 1976-05-18 | British Industrial Plastics Limited | Filled aminoplast moulding materials |
US4007142A (en) * | 1974-04-24 | 1977-02-08 | Balm Paints Limited | Amine resin and process |
GB8311136D0 (en) * | 1983-04-25 | 1983-06-02 | Lepetit Spa | Immobilised oligopeptides |
-
1985
- 1985-01-04 GB GB858500209A patent/GB8500209D0/en active Pending
- 1985-12-31 AT AT85309560T patent/ATE60991T1/de not_active IP Right Cessation
- 1985-12-31 DE DE8585309560T patent/DE3581921D1/de not_active Expired - Lifetime
- 1985-12-31 EP EP85309560A patent/EP0187547B1/en not_active Expired - Lifetime
-
1986
- 1986-01-03 DK DK003386A patent/DK164485C/da not_active IP Right Cessation
- 1986-01-03 AU AU51833/86A patent/AU589587B2/en not_active Ceased
- 1986-01-03 CA CA000498931A patent/CA1305053C/en not_active Expired - Lifetime
- 1986-01-04 JP JP61000137A patent/JPH075474B2/ja not_active Expired - Fee Related
-
1989
- 1989-11-17 US US07/438,352 patent/US5037883A/en not_active Expired - Lifetime
-
1994
- 1994-05-31 JP JP6140759A patent/JP2620517B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH075474B2 (ja) | 1995-01-25 |
DE3581921D1 (de) | 1991-04-04 |
EP0187547B1 (en) | 1991-02-27 |
EP0187547A3 (en) | 1987-07-22 |
JPH07300428A (ja) | 1995-11-14 |
CA1305053C (en) | 1992-07-14 |
US5037883A (en) | 1991-08-06 |
JP2620517B2 (ja) | 1997-06-18 |
AU589587B2 (en) | 1989-10-19 |
GB8500209D0 (en) | 1985-02-13 |
ATE60991T1 (de) | 1991-03-15 |
DK164485B (da) | 1992-07-06 |
DK3386D0 (da) | 1986-01-03 |
DK3386A (da) | 1986-07-05 |
EP0187547A2 (en) | 1986-07-16 |
JPS61243026A (ja) | 1986-10-29 |
AU5183386A (en) | 1986-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK164485C (da) | Polymerholdige medikamenter, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat indeholdende mindst et saadant medikament | |
DK0693924T4 (da) | Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil | |
ATE204467T1 (de) | Orale darreichungsform | |
KR960702323A (ko) | 폴리머를 사용하는 비타민 b₁₂ 흡수시스템의 증폭 (amplification of the vitamin b₁₂ uptake system using polymers) | |
DE3687458D1 (de) | Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln | |
DE3650753D1 (de) | Auf einmaligen sequenzen innerhalb des veränderlichen gebiets des t-zellrezeptors basierte diagnosemittel und deren verwendung | |
BR9713486A (pt) | Preparações farmacêuticas compreendidas de sais de ácido hialurÈnico com anestésicosm locais. | |
ES2016620B3 (es) | Sistema para liberar medicamentos con bioaceptabilidad mejorada. | |
EP0228192A3 (en) | Renin-inhibitory oligopeptides, their preparation and use | |
DE69900756D1 (de) | Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung | |
ES2111653T3 (es) | Gen que codifica la heparinasa de flavobacterium heparinum. | |
ES2144418T3 (es) | Peptidos de receptores de celulas t como agentes terapeuticos para enfermedades relacionadas con el sistema inmunitario. | |
IL79816A (en) | Pharmaceutical compositions comprising a drug-polymer matrix | |
DK0707473T3 (da) | Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler | |
FI893681A (fi) | N-2,3-butadienyltri- och tetra-aminoalkanderivat. | |
ATE89317T1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
ATE93527T1 (de) | Peptide und deren benutzung. | |
ITMI911950A1 (it) | Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante. | |
KR930004326A (ko) | 콘드로모듈린-ii 단백질 | |
FI962985A (fi) | Oraalinen lääkemuoto, jossa on happamia vaikuttavia aineita, ja menetelmä sen valmistamiseksi | |
DK328189D0 (da) | Konjugater mellem et laegemiddel og en nitrophenylgruppe samt farmaceutisk anvendelse deraf | |
DE68909451D1 (de) | Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
RU95105590A (ru) | Гепатотропные конъюгаты антивирусных лекарственных средств, их носители, содержащие их фармацевтические композиции, способ получения конъюгатов | |
ATE75485T1 (de) | Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen. | |
TH22632A (th) | ยาเตรียมทางเภสัชศาสตร์ชนิดใหม่สำหรับควบคุมความเจ็บปวด |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |
Country of ref document: DK |